Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Elizabeth Arden Inc Issues FY, Q1 2014 Guidance Below Analysts' Estimates


Thursday, 8 Aug 2013 06:59am EDT 

Elizabeth Arden Inc announced that for fiscal 2014, the Company expects net sales to increase by 3.0% to 5.0%, including an expected unfavorable impact from foreign currency of approximately 1.0%, as compared to the prior year period, and for earnings per diluted share (EPS) to be in the range of $2.15 to $2.30. The earnings guidance includes a negative impact of $0.19 per share resulting from foreign currency translation as compared to rates in effect for fiscal 2013. For the first quarter of 2014, the Company expects sales to be flat to down 1% in comparison to the prior year period, including an unfavorable impact from foreign currency translation of approximately 1.0%, and for adjusted earnings per diluted share to be in the range of $0.13 to $0.18. The Company reported revenue of $1.345 billion for fiscal 2013 and revenue of $267.58 million in the third quarter of 2013. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $1.452 billion and EPS of $2.85 for fiscal 2014; and revenue of $362.11 million and EPS of $0.50 for the first quarter of 2014. 

Company Quote

21.11
-0.19 -0.89%
1:35pm EDT